Ajanta Pharma informs about company updates

10 Apr 2017 Evaluate

Ajanta Pharma has informed that the Company’s formulation facility at Dahej was inspected by US FDA from 3rd to 7th April, 2017. At the end of the inspection, no Form 483 was issued to the Company.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2917.50 147.25 (5.32%)
01-Jan-2026 14:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.25
Dr. Reddys Lab 1250.80
Cipla 1499.60
Zydus Lifesciences 913.40
Lupin 2101.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×